M Ventures (Merck)

Cambridge, Massachusetts
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Founded:2009
Firm Location:Cambridge, Massachusetts • London • Amsterdam, Netherlands • Israel • Germany • Barcelona, Spain • Netherlands • Switzerland • Bonn, Germany
M Ventures (Merck) Team
Photo of Bauke Anninga, Principal at M Ventures (Merck)
Bauke Anninga
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London, Investors in Netherlands
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in London (Other Lists), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Tobias Egle, Analyst at M Ventures (Merck)
Tobias Egle
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
Investors in Material Science (Series A), Investors in Material Science (Seed), Investors in Impact (Series A), Investors in Impact (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in EnergyTech (Series A), Investors in EnergyTech (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in Material Science (Series A), Investors in Material Science (Seed), Investors in Impact (Series A), Investors in Impact (Seed), Investors in DeepTech (Series A), Investors in EnergyTech (Series A), Investors in DeepTech (Seed), Investors in EnergyTech (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in Boston / New England (Other Lists), Investors in ClimateTech/CleanTech (Seed)
Photo of Daniel Franke, Principal at M Ventures (Merck)
Daniel Franke
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
Investors in Semiconductors (Series B), Investors in Impact (Series B), Investors in DeepTech (Series B), Investors in Semiconductors (Series A), Investors in Semiconductors (Seed), Investors in Impact (Series A), Investors in Impact (Seed), Investors in DeepTech (Series A), Investors in ClimateTech/CleanTech (Series B), Investors in DeepTech (Seed), Investors in Digital Health (Series B), Investors in Semiconductors (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Semiconductors (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Semiconductors (Seed), Investors in Digital Health (Seed), Investors in DeepTech (Series B), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Impact (Series B), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Impact (Series A), Investors in ClimateTech/CleanTech (Series B), Investors in DeepTech (Series A), Investors in Impact (Seed), Investors in Digital Health (Series B), Investors in DeepTech (Seed), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in Digital Health (Seed), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Hakan Goker, Managing Director at M Ventures (Merck)
Hakan Goker
M Ventures (Merck)·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Photo of Nadiya Ishnazarova, Investor at M Ventures (Merck)
Nadiya Ishnazarova
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Photo of Therese Liechtenstein, Investor at M Ventures (Merck)
Therese Liechtenstein
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Switzerland
Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in BioTech (Series B), Investors in AI (Series B), Investors in BioTech (Series A), Investors in AI (Series A), Investors in BioTech (Seed), Investors in AI (Seed)
Photo of Owen Lozman, Managing Director at M Ventures (Merck)
Owen Lozman
M Ventures (Merck)·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London, Investors in Amsterdam (Netherlands)
Photo of Sarah Luppino, Associate at M Ventures (Merck)
Sarah Luppino
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Barcelona (Spain)
Investors in Semiconductors (Series B), Investors in Impact (Series B), Investors in Semiconductors (Series A), Investors in Semiconductors (Seed), Investors in DeepTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Impact (Series A), Investors in Impact (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in ClimateTech/CleanTech (Seed)
Photo of Jonathan Nash, Associate at M Ventures (Merck)
Jonathan Nash
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in London (Other Lists), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Christian Patze, Investor at M Ventures (Merck)
Christian Patze
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Germany
Photo of Radhika Ramachandran, Associate at M Ventures (Merck)
Radhika Ramachandran
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Germany
Photo of Sebastian Schöfer, Investor at M Ventures (Merck)
Sebastian Schöfer
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Bonn (Germany)
Photo of Anique ter Braake, Associate at M Ventures (Merck)
Anique ter Braake
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Netherlands
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Christian Uhrich, Principal at M Ventures (Merck)
Christian Uhrich
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Germany
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Noga Yerushalmi, Investor at M Ventures (Merck)
Noga Yerushalmi
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Israel
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Cheryl Zimberlin, Investor at M Ventures (Merck)
Cheryl Zimberlin
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)